Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

GSK plc (GSK) Form 6-K — Oct 6, 2026

$GSKForm 6-KFiled Oct 6, 2026, 10:43 AM ET0001654954-26-008813Original filing

GSK plc filed a 6-K notifying the market that 19,352 ordinary shares of 31¼ pence were admitted to trading on the London Stock Exchange Main Market. The admission covers the period from 7 August 2026 to 2 October 2026 and falls under the existing block listing for the GlaxoSmithKline plc Share Save Plan 2022, an employee share plan. Following the admission, the total number of ordinary shares admitted to trading is 4,316,311,662, and the new shares are fully fungible with existing shares.

Key figures

Shares Admitted
19352
Total Shares Admitted Following
4316311662
Plan
GlaxoSmithKline plc Share Save Plan 2022
Date range
7 August 2026 – 2 October 2026
Ordinary share nominal value
31¼ pence

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.